We are live on !
Find out more
LP
LGL Partners Portfolio holdings
AUM
$273M
Turnover
24.66%
1-Year Est. Return
24.15%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+24.15%
3 Year Est. Return
+68.92%
5 Year Est. Return
+65.82%
10 Year Est. Return
+207.49%
AUM
$273M
AUM Growth
+$30.5M
(+13%)
Cap. Flow
-$2.74M
Cap. Flow % of AUM
Cap. Flow %
-1%
Top 10 Holdings %
Top 10 Hldgs %
80.4%
Holding
73
New
7
Increased
40
Reduced
6
Closed
11
Avg Time Held
4.4
years
Top 10 Avg Time Held
3.6
years
Top 20 Avg Time Held
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$550K |
| 2 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$502K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$461K |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$418K |
| 5 |
iShares Core High Dividend ETF
HDV
|
+$358K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.19M |
| 2 |
Liquidia Corp
LQDA
|
+$1.09M |
| 3 |
Coupang
CPNG
|
+$850K |
| 4 |
Sabra Healthcare REIT
SBRA
|
+$794K |
| 5 |
JPMorgan Chase
JPM
|
+$615K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.3% |
| 2 | Financials | 0.82% |
| 3 | Technology | 0.82% |
| 4 | Healthcare | 0.45% |
| 5 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
NVIDIA
NVDA
$5.12T
| $258K | 0.09% |
1,291
+2
| +0.2% | +$411 |
2025 Q2
4 quarters
|
|
52
Alphabet (Google) Class A
GOOGL
$3.97T
| $249K | 0.09% |
698
| – | – |
2025 Q4
2 quarters
|
|
53
GMO Dynamic Allocation ETF
GMOD
$44.2M
| $248K | 0.09% |
9,000
| – | – |
2026 Q1
1 quarter
|
|
54
Caterpillar
CAT
$324B
| $236K | 0.09% |
+221
| New | +$194K |
2026 Q2
0 quarters
|
|
55
iShares Bitcoin Trust
IBIT
$65.3B
| $236K | 0.09% |
7,078
| – | – |
2024 Q4
6 quarters
|
|
56
iShares Future AI & Tech ETF
ARTY
$3.72B
| $229K | 0.08% |
+3,011
| New | +$200K |
2026 Q2
0 quarters
|
|
57
iShares Core US REIT ETF
USRT
$4.27B
| $229K | 0.08% |
3,447
+19
| +0.6% | +$1.22K |
2026 Q1
1 quarter
|
|
58
Linde
LIN
$235B
| $229K | 0.08% |
441
+2
| +0.5% | +$1.01K |
2026 Q1
1 quarter
|
|
59
Applied Materials
AMAT
$298B
| $226K | 0.08% |
+313
| New | +$144K |
2026 Q2
0 quarters
|
|
60
iShares MSCI USA Momentum Factor ETF
MTUM
$18.3B
| $204K | 0.07% |
+595
| New | +$178K |
2026 Q2
0 quarters
|
|
|
61
Sabra Healthcare REIT
SBRA
$5.01B
| $198K | 0.07% |
10,145
-40,000
| -80% | -$794K |
2026 Q1
1 quarter
|
|
62
Phreesia
PHR
$790M
| $128K | 0.05% |
12,487
| – | – |
2025 Q1
5 quarters
|
|
|
63
Coupang
CPNG
$25.1B
| – | – |
-45,000
| Closed | -$850K | – |
|
64
Intel
INTC
$452B
| – | – |
-6,154
| Closed | -$272K | – |
|
|
65
JPMorgan Chase
JPM
$894B
| – | – |
-2,091
| Closed | -$615K | – |
|
|
66
Eli Lilly
LLY
$1.16T
| – | – |
-1,293
| Closed | -$1.19M | – |
|
|
67
Liquidia Corp
LQDA
$3.55B
| – | – |
-29,000
| Closed | -$1.09M | – |
|
68
Nike
NKE
$56.9B
| – | – |
-10,000
| Closed | -$532K | – |
|
69
Oneok
OKE
$59.2B
| – | – |
-2,668
| Closed | -$241K | – |
|
70
Opko Health
OPK
$1.22B
| – | – |
-44,507
| Closed | -$50.7K | – |
|
71
Sprott Physical Silver Trust
PSLV
$11.1B
| – | – |
-10,000
| Closed | -$244K | – |
|
72
Symbotic
SYM
$5.24B
| – | – |
-10,000
| Closed | -$532K | – |
|
73
UNIFI
UFI
$102M
| – | – |
-169,040
| Closed | -$603K | – |
|
Similar funds
MEPT
LGL Partners's Q2 2026 Portfolio in Review
As of Q2 2026, LGL Partners held 73 positions worth $273M, up 13% from $243M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
LGL Partners's Q2 2026 filing shows 7 new, 40 increased, 6 reduced and 11 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 825 shares worth $567K. The largest sale was Eli Lilly, an estimated $1.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 95% a quarter earlier, followed by Financials and Technology.
- LGL Partners's largest Q2 2026 buy was Vanguard S&P 500 ETF: 825 shares worth $567K.
- LGL Partners added most to iShares Expanded Tech-Software Sector ETF in Q2 2026, an estimated $418K increase.
- LGL Partners's biggest Q2 2026 reduction was Sabra Healthcare REIT, cutting an estimated $794K.
- LGL Partners fully exited Eli Lilly in Q2 2026, selling an estimated $1.19M.
- LGL Partners's ten largest holdings make up 80% of its $273M portfolio in Q2 2026.
- LGL Partners opened 7 new positions and closed 11 in Q2 2026.
- LGL Partners's portfolio value rose 13% quarter-over-quarter to $273M.
Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.